Beyond Air Inc (XAIR) is a Healthcare · Medical Devices company listed on NASDAQ. Price $3.22 (+4.55%), Market cap $0.01B, 52-week low–high $0.16 ~ $3.40.
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinic
Financial statements, price targets, institutional (13F) holdings and related news for Beyond Air Inc are updated in real time on BlackAll Trade.
Beyond Air Inc trades at $3.22 (+4.55%). Real-time quotes and charts are available on BlackAll Trade.
Beyond Air Inc has a market cap of about $0.01B.
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three